Risk factors | |
Current smoker | Proportions of smokers. Patients were assumed to be non-smokers if smoking status was not specified. |
Diabetes | Proportion of patients with a medical diagnosisa of diabetes mellitus. Patients were assumed to be non-diabetic if diabetes status was not specified. |
History of CVD | Proportion of patients with a medical diagnosisb of cardiovascular disease |
SBP/DBP | Mean based on the most recent systolic/diastolic blood pressure measurementc |
Process indicators | |
Smoking status recorded | Proportion of patients with smoking status recorded |
BP measured regularly | Proportion of patients with two documented BP measurementsc |
Fasting glucose tested | Proportions of patients with fasting glucose tested |
Total cholesterol tested | Proportions of patients with total cholesterol tested |
WHO/ISH risk score documented | Proportions of patients aged 40 years or more with a WHO/ISH CVD risk score documented by health workers based on age, sex, BP, smoking status, diabtes status, and total blood cholesterol |
WHO/ISH risk score calculatable | Proportions of patients aged 40 years or more with all risk factors (age, sex, BP, smoking status, diabetes status, and total blood cholesterol) recorded to calculated the WHO/ISH CVD risk score. Patients were assumed to be non-smoker if smoking status was not specified and to be non-diabetic if diabetes status was not specified. Predictions charts without total cholesterol were applied for those without measurement. The most recent BP and total cholesterol had to be during the last 24 months. |
High-risk patients | Proportions of patients with a calculatedd WHO/ISHāā„ā30ā% or/and a history of CVD |
BP lowering drug prescribed | Proportions of patients with BP lowering drug prescribed |
Statin prescribed for high-risk patients | Proportions of high-risk patients (calculatedd WHO/ISHāā„ā30ā% or/and history of CVD |
Aspirin prescribed for high-risk patients | Proportions of high-risk patients (calculatedd WHO/ISHāā„ā30ā% or/and history of CVD) prescribed aspirin |
Triple therapy prescribed for high-risk patients | Proportions of high-risk patients (calculatedd WHO/ISHāā„ā30ā% or/and history of CVD) prescribed triple therapy (statin, aspirin, and blood pressure medication) |
Outcome indicator | |
BP at normal range | Proportion of patients whose most recent BP measurementc was at normal range (SBPā<ā140 mmHg and DBPā<ā90 mmHg) |
High-risk patients with BP at normal range | Proportion of high-risk patients (calculatedd WHO/ISHāā„ā30ā% or/and history of CVD) whose most recent BP measurementc was at normal range (SBPā<ā140 mmHg and DBPā<ā90 mmHg) |
Low-risk patients with BP at normal range | Proportion of low-risk patients (calculatedd WHO/ISHā<ā30ā% and no history of CVD) whose most recent BP measurementc was at normal range (SBPā<ā140 mmHg and DBPā<ā90 mmHg) |